AI in Pharmacy Standards and Drug Supply Chain Upgrades | TWIRx

AI in Pharmacy Standards and Drug Supply Chain UpgradesThis Week in Pharmacy — July 17, 2026

Artificial intelligence and supply chain modernization are reshaping pharmacy practice, patient access, and healthcare operations.

In this episode of This Week in Pharmacy, host Todd Eury speaks with leaders from URAC and Cencora about responsible AI adoption and the growing gap between drug availability and real-world access.

Guests

Shawn Griffin, MDPresident and CEO, URAC

Brent WilhelmSenior Vice President, Global Supply Chain Center of Excellence, Cencora

Tim WeberPharmacy Operations and Regulatory Executive

AI is already supporting clinical documentation, patient communication, risk prediction, and workflow automation. URAC President and CEO Shawn Griffin, MD, explains why healthcare organizations need clear governance, defined accountability, human oversight, and continuous monitoring before deploying AI at scale.

The discussion addresses transparency, performance evaluation, bias, data integrity, cybersecurity, and the role accreditation standards may play in promoting safe and responsible AI adoption.

Governance and accountability for AI outputs

Human review of AI-supported decisions

Monitoring safety, accuracy, and bias